{"id":260862,"date":"2026-09-22T12:13:54","date_gmt":"2026-09-22T06:43:54","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=260862"},"modified":"2026-09-22T12:13:55","modified_gmt":"2026-09-22T06:43:55","slug":"aurobindo-pharma-stock-signals-investors-are-watching-2","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/aurobindo-pharma-stock-signals-investors-are-watching-2\/","title":{"rendered":"Aurobindo Pharma: 7 Stock Signals Investors Are Watching Right Now"},"content":{"rendered":"
<\/div>\n

Aurobindo Pharma CMP Rs 1,668.30. 52W range Rs 1,066.00 to Rs 1,706.70. Mcap Rs 92,940 crore. PE 26.24.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Aurobindo Pharma stock signals right now span an earnings picture, a shareholding pattern where a full FII breakup was not available from the data source used here, and a technical setup where the stock trades within its 52 week range of Rs 1,066.00 to Rs 1,706.70. and valuation sits at a P\/E of 26.24. Corporate developments in the a major Indian pharmaceutical company manufacturing active pharmaceutical ingredients, generic pharmaceuticals and related services space add further context investors are tracking alongside these numbers. None of the seven signals here amounts to a buy or sell call on its own.<\/p>\n<\/div>\n

Aurobindo Pharma stock signals are unusually layered right now, with the company trading at Rs 1,668.30, the stock trades close to its 52 week high of Rs 1,706.70 and well above its 52 week low of Rs 1,066.00, up over 45 percent over the past year. Aurobindo Pharma is a well tracked name in the a major Indian pharmaceutical company manufacturing active pharmaceutical ingredients, generic pharmaceuticals and related services space, and no single headline captures where the stock stands today.<\/p>\n

This article does not make a buy, hold or sell call on Aurobindo Pharma. It lays out seven signals investors commonly watch, each sourced from the company’s latest exchange disclosures and financial statements, so readers can form their own view of what is currently working for the stock and what still needs to be watched.<\/p>\n

Click Here to Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n